Psilocybin Administration to Healthy Participants: Safety and Feasibility in a Placebo-Controlled Study

被引：0
作者：
Rucker, James [1 ]
Young, Allan [1 ]
Williams, Samuel [1 ]
Stansfield, Susan [1 ]
Eriksson, Hans [1 ]
Malievskaia, Ekaterina [1 ]
机构：
[1] COMPASS Pathways, London, England
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Psilocybin; Psychedelics; Emotional Processing; Cognitive Functioning;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W111
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [21] Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG
    Euphrosyne Gouzoulis-Mayfrank
    Mathias Schreckenberger
    Osama Sabri
    Christoph Arning
    Bernhard Thelen
    Manfred Spitzer
    Karl-Artur Kovar
    Leopold Hermle
    Udalrich Büll
    Henning Sass
    Neuropsychopharmacology, 1999, 20 : 565 - 581
  • [22] Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials
    Swieczkowski, Damian
    Kwasny, Aleksander
    Pruc, Michal
    Gaca, Zuzanna
    Szarpak, Lukasz
    Cubala, Wieslaw J.
    PSYCHIATRY RESEARCH, 2025, 344
  • [23] Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers -: A double-blind, placebo-controlled PET study with [18F]FDG
    Gouzoulis-Mayfrank, E
    Schreckenberger, M
    Sabri, O
    Arning, C
    Thelen, B
    Spitzer, M
    Kovar, KA
    Hermle, L
    Büll, U
    Sass, H
    NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) : 565 - 581
  • [24] Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
    Klaiber, Aaron
    Schmid, Yasmin
    Becker, Anna M.
    Straumann, Isabelle
    Erne, Livio
    Jelusic, Alen
    Thomann, Jan
    Luethi, Dino
    Liechti, Matthias E.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
  • [25] Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man
    Hasler, F
    Bourquin, D
    Brenneisen, R
    Vollenweider, FX
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (02) : 331 - 339
  • [26] Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
    Sloshower, Jordan
    Zeifman, Richard J.
    Guss, Jeffrey
    Krause, Robert
    Safi-Aghdam, Hamideh
    Pathania, Surbhi
    Pittman, Brian
    D'Souza, Deepak Cyril
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [27] Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study
    Jensen, Mathias Ebbesen
    Stenbaek, Dea Siggaard
    Messell, Catharina Dragsted
    Poulsen, Emil Deleuran
    Varga, Tibor V.
    Fisher, Patrick McDonald
    Nielsen, Marie Katrine Klose
    Johansen, Sys Stybe
    Volkow, Nora D.
    Knudsen, Gitte Moos
    Fink-Jensen, Anders
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025,
  • [28] MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
    Robin J. Murphy
    Rachael L. Sumner
    William Evans
    David Menkes
    Ingo Lambrecht
    Rhys Ponton
    Frederick Sundram
    Nicholas Hoeh
    Sanya Ram
    Lisa Reynolds
    Suresh Muthukumaraswamy
    Trials, 22
  • [29] Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
    Holze, Friederike
    Vizeli, Patrick
    Ley, Laura
    Mueller, Felix
    Dolder, Patrick
    Stocker, Melanie
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Borgwardt, Stefan
    Liechti, Matthias E.
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (03) : 537 - 544
  • [30] Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
    Ching, Terence H. W.
    Grazioplene, Rachael
    Bohner, Calvin
    Kichuk, Stephen. A. A.
    DePalmer, Giuliana
    D'Amico, Elizabeth
    Eilbott, Jeffrey
    Jankovsky, Anastasia
    Burke, Michelle
    Hokanson, Jamila
    Martins, Brad
    Witherow, Chelsea
    Patel, Prerana
    Amoroso, Lucia
    Schaer, Henry
    Pittenger, Christopher
    Kelmendi, Benjamin
    FRONTIERS IN PSYCHIATRY, 2023, 14
12345